| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.007 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.44 | 0.009 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.009 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |